A Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of IONIS-ENaCRx in Healthy Volunteers and Patients With Cystic Fibrosis
Clinical trial NCT03647228 · COMPLETED
Trial details
- NCT number
- NCT03647228
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-13
- Primary completion
- 2020-10-13
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.